Logo
BioBucks
Subscribe
Search
Log In
BioBucks
BioBucks Team
BioBucks Team
Wednesday: Beam's base editor clears its 12-month pain-crisis bar

Nov 11, 2026

•

4 min read

Wednesday: Beam's base editor clears its 12-month pain-crisis bar

Beam heads for a first base-editing BLA, PepGen nearly doubles, and pimicotinib clears FDA.

BioBucks Team
BioBucks Team

BioBucks

Daily biotech dealflow + market tape in 5 minutes — for VC, BD&L, and public biotech investors.


Quick Links

Subscribe

Subscription

Signup

Search

© 2026 BioBucks.
beehiivPowered by beehiiv